Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

MULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indices.

McGinnis CS, Patterson DM, Winkler J, Conrad DN, Hein MY, Srivastava V, Hu JL, Murrow LM, Weissman JS, Werb Z, Chow ED, Gartner ZJ.

Nat Methods. 2019 Jul;16(7):619-626. doi: 10.1038/s41592-019-0433-8. Epub 2019 Jun 17.

2.

Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras.

Liang SI, van Lengerich B, Eichel K, Cha M, Patterson DM, Yoon TY, von Zastrow M, Jura N, Gartner ZJ.

Cell Rep. 2018 Mar 6;22(10):2593-2600. doi: 10.1016/j.celrep.2018.02.031.

3.

Injectable Polymeric Cytokine-Binding Nanowires Are Effective Tissue-Specific Immunomodulators.

Zamecnik CR, Lowe MM, Patterson DM, Rosenblum MD, Desai TA.

ACS Nano. 2017 Nov 28;11(11):11433-11440. doi: 10.1021/acsnano.7b06094. Epub 2017 Nov 15.

4.

Orthogonal bioorthogonal chemistries.

Patterson DM, Prescher JA.

Curr Opin Chem Biol. 2015 Oct;28:141-9. doi: 10.1016/j.cbpa.2015.07.006. Epub 2015 Aug 10. Review.

PMID:
26276062
5.

Outcomes of patients with low-risk endometrial cancer surgically staged without lymphadenectomy based on intra-operative evaluation.

Bell JG, Patterson DM, Klima J, Harvison M, Rath K, Reid G.

Gynecol Oncol. 2014 Sep;134(3):505-9. doi: 10.1016/j.ygyno.2014.06.028. Epub 2014 Jul 5.

PMID:
25003655
6.

Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C.

Chin PK, Wright DF, Zhang M, Wallace MC, Roberts RL, Patterson DM, Jensen BP, Barclay ML, Begg EJ.

Drugs R D. 2014 Jun;14(2):113-23. doi: 10.1007/s40268-014-0045-9.

7.

Improved cyclopropene reporters for probing protein glycosylation.

Patterson DM, Jones KA, Prescher JA.

Mol Biosyst. 2014 Jul;10(7):1693-7. doi: 10.1039/c4mb00092g. Epub 2014 Mar 12.

PMID:
24623192
8.

Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran.

Chin PK, Patterson DM, Zhang M, Jensen BP, Wright DF, Barclay ML, Begg EJ.

Br J Clin Pharmacol. 2014 Sep;78(3):630-8. doi: 10.1111/bcp.12366.

9.

A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time.

Chin PK, Wright DF, Patterson DM, Doogue MP, Begg EJ.

Br J Clin Pharmacol. 2014 Sep;78(3):599-609. doi: 10.1111/bcp.12364. Review.

10.

Finding the right (bioorthogonal) chemistry.

Patterson DM, Nazarova LA, Prescher JA.

ACS Chem Biol. 2014 Mar 21;9(3):592-605. doi: 10.1021/cb400828a. Epub 2014 Jan 30. Review.

PMID:
24437719
11.

Isomeric cyclopropenes exhibit unique bioorthogonal reactivities.

Kamber DN, Nazarova LA, Liang Y, Lopez SA, Patterson DM, Shih HW, Houk KN, Prescher JA.

J Am Chem Soc. 2013 Sep 18;135(37):13680-3. doi: 10.1021/ja407737d. Epub 2013 Sep 6.

PMID:
24000889
12.

Functionalized cyclopropenes as bioorthogonal chemical reporters.

Patterson DM, Nazarova LA, Xie B, Kamber DN, Prescher JA.

J Am Chem Soc. 2012 Nov 14;134(45):18638-43. doi: 10.1021/ja3060436. Epub 2012 Nov 1.

PMID:
23072583
13.

Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children.

Hassan SF, Mathur S, Magliaro TJ, Larimer EL, Ferrell LB, Vasudevan SA, Patterson DM, Louis CU, Russell HV, Nuchtern JG, Kim ES.

J Pediatr Surg. 2012 Jun;47(6):1261-6. doi: 10.1016/j.jpedsurg.2012.03.040. Review.

PMID:
22703803
14.

Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors.

Patterson DM, Zweifel M, Middleton MR, Price PM, Folkes LK, Stratford MR, Ross P, Halford S, Peters J, Balkissoon J, Chaplin DJ, Padhani AR, Rustin GJ.

Clin Cancer Res. 2012 Mar 1;18(5):1415-25. doi: 10.1158/1078-0432.CCR-11-2414. Epub 2012 Jan 10.

15.

Preclinical models of pediatric solid tumors (neuroblastoma) and their use in drug discovery.

Patterson DM, Shohet JM, Kim ES.

Curr Protoc Pharmacol. 2011 Mar;Chapter 14:Unit 14.17. doi: 10.1002/0471141755.ph1417s52.

PMID:
21935903
16.

A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.

Shohet JM, Ghosh R, Coarfa C, Ludwig A, Benham AL, Chen Z, Patterson DM, Barbieri E, Mestdagh P, Sikorski DN, Milosavljevic A, Kim ES, Gunaratne PH.

Cancer Res. 2011 Jun 1;71(11):3841-51. doi: 10.1158/0008-5472.CAN-10-4391. Epub 2011 Apr 15.

17.

Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.

Patterson DM, Gao D, Trahan DN, Johnson BA, Ludwig A, Barbieri E, Chen Z, Diaz-Miron J, Vassilev L, Shohet JM, Kim ES.

Angiogenesis. 2011 Sep;14(3):255-66. doi: 10.1007/s10456-011-9210-8. Epub 2011 Apr 12.

PMID:
21484514
18.

Nonconvulsive status epilepticus and leucoencephalopathy after high-dose methotrexate.

Patterson DM, Aries J, Hyare H, Holder D, Rees J, Lee SM.

J Clin Oncol. 2011 Jun 1;29(16):e459-61. doi: 10.1200/JCO.2010.33.9598. Epub 2011 Mar 21. No abstract available.

PMID:
21422437
19.

Novel use of glycopyrrolate (Robinul) in the treatment of anastomotic leak after repair of esophageal atresia and tracheoesophageal fistula.

Mathur S, Vasudevan SA, Patterson DM, Hassan SF, Kim ES.

J Pediatr Surg. 2011 Mar;46(3):e29-32. doi: 10.1016/j.jpedsurg.2010.11.040.

PMID:
21376184
20.

Glucarpidase following high-dose methotrexate: update on development.

Patterson DM, Lee SM.

Expert Opin Biol Ther. 2010 Jan;10(1):105-11. doi: 10.1517/14712590903468677. Review.

PMID:
19925307
21.

Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type II.

Yan D, Ouyang X, Patterson DM, Du LL, Jacobson SG, Liu XZ.

J Hum Genet. 2009 Dec;54(12):732-8. doi: 10.1038/jhg.2009.107. Epub 2009 Oct 30.

22.

Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy.

Patterson DM, Padhani AR, Collins DJ.

Nat Clin Pract Oncol. 2008 Apr;5(4):220-33. doi: 10.1038/ncponc1073. Epub 2008 Feb 26. Review.

PMID:
18301415
23.

Cochlear implantation in organ transplantation.

Patterson DM, Telischi FF, Connell SS, Ulubil SA, Hodges AV, Eshraghi AA, Balkany TJ.

Laryngoscope. 2008 Jan;118(1):116-9. doi: 10.1097/MLG.0b013e31814a52e2.

PMID:
18251033
24.

A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites.

Patterson DM, Murugaesu N, Holden L, Seckl MJ, Rustin GJ.

Int J Gynecol Cancer. 2008 Jan-Feb;18(1):43-50. Epub 2007 Apr 26.

PMID:
17466047
25.

Vascular damaging agents.

Patterson DM, Rustin GJ.

Clin Oncol (R Coll Radiol). 2007 Aug;19(6):443-56. Epub 2007 Apr 24. Review.

PMID:
17459681
26.

Controversies in the management of germ cell tumours of the ovary.

Patterson DM, Rustin GJ.

Curr Opin Oncol. 2006 Sep;18(5):500-6. Review.

PMID:
16894300
27.

Safety of modified radical neck dissection for differentiated thyroid carcinoma.

Kupferman ME, Patterson DM, Mandel SJ, LiVolsi V, Weber RS.

Laryngoscope. 2004 Mar;114(3):403-6.

PMID:
15091209
28.

The response of breeding doses to nematodiasis: segregation into "responders" and "non-responders".

Patterson DM, Jackson F, Huntley JF, Stevenson LM, Jones DG, Jackson E, Russel AJ.

Int J Parasitol. 1996 Nov;26(11):1295-303.

PMID:
9024875
29.

Studies on caprine responsiveness to nematodiasis: segregation of male goats into responders and non-responders.

Patterson DM, Jackson F, Huntley JF, Stevenson LM, Jones DG, Jackson E, Russel AJ.

Int J Parasitol. 1996 Feb;26(2):187-94.

PMID:
8690543

Supplemental Content

Loading ...
Support Center